SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Evolent Health, Inc. – ‘10-Q’ for 3/31/16 – ‘ZIP’

On:  Monday, 5/16/16, at 4:13pm ET   ·   For:  3/31/16   ·   Accession #:  1628908-16-51   ·   File #:  1-37415

Previous ‘10-Q’:  ‘10-Q’ on 11/6/15 for 9/30/15   ·   Next:  ‘10-Q’ on 8/9/16 for 6/30/16   ·   Latest:  ‘10-Q’ on 5/10/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/16/16  Evolent Health, Inc.              10-Q        3/31/16   66:5.3M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    531K 
 2: EX-10.1     Material Contract                                   HTML     71K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
13: R1          Document and Entity Information                     HTML     43K 
14: R2          Consolidated Balance Sheets                         HTML    104K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
16: R4          Consolidated Statements of Operations               HTML     94K 
17: R5          Consolidated Statements of Cash Flows               HTML     97K 
18: R6          Consolidated Statements of Changes in               HTML    120K 
                Shareholders' Equity (Deficit) and Redeemable                    
                Preferred Stock                                                  
19: R7          Organization                                        HTML     32K 
20: R8          Basis of Presentation and Summary of Significant    HTML     40K 
                Accounting Policies                                              
21: R9          Recently Issued Accounting Standards                HTML     32K 
22: R10         Acquisitions and Business Combinations              HTML     70K 
23: R11         Investments                                         HTML     80K 
24: R12         Property and Equipment, Net                         HTML     44K 
25: R13         Goodwill and Intangible Assets, Net                 HTML     78K 
26: R14         Commitments and Contingencies                       HTML     58K 
27: R15         Earnings (Loss) Per Common Share                    HTML     52K 
28: R16         Stock-based Compensation                            HTML     46K 
29: R17         Income Taxes                                        HTML     28K 
30: R18         Equity Method Investment                            HTML     35K 
31: R19         Non-controlling Interests                           HTML     30K 
32: R20         Related Parties                                     HTML     25K 
33: R21         Basis of Presentation and Summary of Significant    HTML     36K 
                Accounting Policies (Policies)                                   
34: R22         Basis of Presentation and Summary of Significant    HTML     36K 
                Accounting Policies (Tables)                                     
35: R23         Acquisitions and Business Combinations (Tables)     HTML     44K 
36: R24         Investments (Tables)                                HTML     79K 
37: R25         Property and Equipment, Net (Tables)                HTML     39K 
38: R26         Goodwill and Intangible Assets, Net (Tables)        HTML     64K 
39: R27         Commitments and Contingencies (Tables)              HTML     38K 
40: R28         Earnings (Loss) Per Common Share (Tables)           HTML     44K 
41: R29         Stock-based Compensation (Tables)                   HTML     47K 
42: R30         Equity Method Investment (Tables)                   HTML     31K 
43: R31         Non-controlling Interests (Tables)                  HTML     28K 
44: R32         Organization (Details)                              HTML     51K 
45: R33         Basis of Presentation and Summary of Significant    HTML     34K 
                Accounting Policies - Additional Information                     
                (Details)                                                        
46: R34         Acquisitions and Business Combinations - Passport   HTML     54K 
                (Details)                                                        
47: R35         Acquisitions and Business Combinations - Offering   HTML     71K 
                Reorganization (Details)                                         
48: R36         Acquisitions and Business Combinations - Vestica    HTML     33K 
                (Details)                                                        
49: R37         Investments - Investment Summary (Details)          HTML     38K 
50: R38         Investments - Contractual Maturity (Details)        HTML     52K 
51: R39         Property and Equipment, Net (Details)               HTML     45K 
52: R40         Goodwill and Intangible Assets, Net (Details)       HTML     63K 
53: R41         Commitments and Contingencies - Additional          HTML     36K 
                Information (Details)                                            
54: R42         Commitments and Contingencies - Concentration Risk  HTML     41K 
                (Details)                                                        
55: R43         Earnings (Loss) Per Common Share - Computation of   HTML     43K 
                Earnings per Share (Details)                                     
56: R44         Earnings (Loss) Per Common Share - Antidilutive     HTML     30K 
                Securities (Details)                                             
57: R45         Stock-based Compensation - Compensation Expense     HTML     31K 
                (Details)                                                        
58: R46         Stock-based Compensation - Awards Granted           HTML     25K 
                (Details)                                                        
59: R47         Income Taxes (Details)                              HTML     35K 
60: R48         Equity Method Investment (Details)                  HTML     27K 
61: R49         Equity Method Investment - Summarized Financial     HTML     35K 
                Information (Details)                                            
62: R50         Non-controlling Interests (Details)                 HTML     35K 
63: R51         Related Parties (Details)                           HTML     20K 
65: XML         IDEA XML File -- Filing Summary                      XML    113K 
64: EXCEL       IDEA Workbook of Financial Reports                  XLSX     62K 
 7: EX-101.INS  XBRL Instance -- evh-20160331                        XML   1.29M 
 9: EX-101.CAL  XBRL Calculations -- evh-20160331_cal                XML    151K 
10: EX-101.DEF  XBRL Definitions -- evh-20160331_def                 XML    545K 
11: EX-101.LAB  XBRL Labels -- evh-20160331_lab                      XML   1.10M 
12: EX-101.PRE  XBRL Presentations -- evh-20160331_pre               XML    691K 
 8: EX-101.SCH  XBRL Schema -- evh-20160331                          XSD    115K 
66: ZIP         XBRL Zipped Folder -- 0001628908-16-000051-xbrl      Zip    152K 


‘ZIP’   —   XBRL Zipped Folder — 0001628908-16-000051-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:evh-20160331.xml
evh-20160331.xsd
evh-20160331_cal.xml
evh-20160331_def.xml
evh-20160331_lab.xml
evh-20160331_pre.xml


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/24  Evolent Health, Inc.              10-K       12/31/23  144:17M
 2/24/23  Evolent Health, Inc.              10-K       12/31/22  148:19M
 2/24/22  Evolent Health, Inc.              10-K       12/31/21  154:19M
 2/26/21  Evolent Health, Inc.              10-K       12/31/20  152:19M
Top
Filing Submission 0001628908-16-000051   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 8:33:10.1am ET